Analog Devices ( ADI - Get Report) was upgraded at Jefferies to buy. $56 price target. Company should continue to return the majority of its cash to shareholders in the coming years, Jefferies said.

Adtran ( ADTN) was upgraded at Goldman Sachs to buy from neutral. $28 price target. Company should benefit from a multiyear upgrade cycle, Goldman said.

Advanced Micro ( AMD) was upgraded to buy from underperform at Bank of America/Merrill Lynch. $6 price target. Estimates were also increased, as the company is gaining market share with consoles.

Advanced Micro was upgraded at Canaccord Genuity to buy from hold. $5 price target. Ramp in the embedded business should continue to accelerate, Canaccord Genuity said.

On Assignment ( ASGN) was downgraded at Deutsche Bank to hold from buy. Valuation call, based on a $29 price target, Deutsche Bank said.

Concur Technologies ( CNQR) was initiated with a neutral rating at J.P. Morgan. Valuation call, based on an $80 price target, J.P. Morgan said.

China Cord Blood ( CO) was upgraded to buy at TheStreet Ratings.

Community Health ( CYH) was initiated with a buy rating at Keybanc. $58 price target. Company has a solid track record and should receive above-average benefits from health care reform, Keybanc said.

Sourcefire ( FIRE) was downgraded at UBS to neutral from buy based on valuation. Price target is $62.

Finisar ( FNSR) was upgraded at Needham to strong buy from buy. $22 price target. Management meetings suggest that positioning and visibility are improving, Needham said.

Hess ( HES - Get Report) was upgraded at J.P. Morgan to overweight from neutral. $84 price target. Asset sale program can help unlock value, J.P. Morgan said.

Health Management ( HMA) was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $16 price target, Credit Suisse said.

Jive Software ( JIVE) was downgraded at UBS to neutral from buy. Valuation and sluggish demand for enterprise software, said UBS. Price target is $19.

KB Home ( KBH) was upgraded at CRT Capital to buy from hold. $23 price target. Earnings are coming in well ahead of expectations, CRT Capital said.

Lamar ( LAMR) was upgraded at Citigroup to buy from neutral. The IRS is expected to rule in favor of the REIT transition, said Citigroup. Price target goes to $53.

Linear Technology ( LLTC) was upgraded at Jefferies to buy. $44 price target. Company is leveraged to higher automotive and industrial growth, Jefferies said.

Optical Cable ( OCC) was downgraded to hold at TheStreet Ratings.

ON Semiconductor ( ONNN) was downgraded at Jefferies to hold. $8.50 price target. Company may face multiple compression, as the chip sector is entering the late innings of the cycle, Jefferies said.

Palo Alto Networks ( PANW - Get Report) was upgraded at UBS to buy from neutral. Unjustified low valuation despite industry leading growth, said UBS. Price target is $55.

Sprint Nextel ( S - Get Report) was downgraded at Citigroup to neutral from buy. Margin expansion from Network Vision is priced in, said Citigroup. Price target is now $7.50.

Sprint Nextel was upgraded at Deutsche Bank to buy from hold. New analyst has an $8 price target. Company will be the king of new spectrum and can drive above-average growth over the next few years, Deutsche Bank said.

Tenet Healthcare ( THC) was initiated with a hold rating at Keybanc. Valuation call, as the stock is up 115% over the past year, Keybanc said.


AmerisourceBergen ( ABC) numbers were boosted at Credit Suisse. Shares are now seen reaching $64. WAG deal should add to earnings, Credit Suisse said. Outperform rating.

Allergan ( AGN) price target was reduced at Lazard Capital Markets. Shares are now seen reaching $100. Restasis could face increased competition from generics, Lazard Capital Markets said. Buy rating.

Axiall ( AXLL) numbers were cut at UBS. Earnings estimates were reduced on weak demand and operation issues, said UBS said. Price target is reduced to $44.

CBS ( CBS) price target was raised at Citigroup to $54. Reflects buyback enthusiasm, said Citigroup.

Family Dollar ( FDO) numbers were raised at Goldman Sachs. Shares are now seen reaching $69. Estimates were also increased, as the company is realizing better operating leverage, Goldman Sachs said. Neutral rating.

Mead Johnson Nutrition ( MJN) numbers were cut at Citigroup. Estimates were reduced given ongoing issues in Hong Kong, dairy inflation and China price pressures, said Citigroup. Price target goes to $77.

National Retail ( NNN) estimates were raised at UBS. Reflect the recent financing and increased acquisition estimates, said UBS. Price target is $33.50.

Occidental Petroleum ( OXY) price target was boosted at Citigroup to $93. A potential breakup should lead to limited upside in the stock, Citi said.

Synchronoss ( SNCR) was added to the Best Ideas List at Wedbush. Pullback has created an attractive buying opportunity, Wedbush said. Outperform rating and $35 price target.

>To submit a news tip, email:

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.